A similar phenomenon has been described for EphB2, where the loss of expression was associated with cancer progression (Batlle et al, 2005; Lugli et al, 2005; Guo et al, 2006), and higher EphB2 expression was associated with prolonged survival (Guo et al, 2006). Here, EPHB2 is linked to cancer.